Chibanishi General Hospital provides diagnoses and treatments based on cutting-edge medical care, with the policies of "Providing worry-free hospital care to patients" and "Promoting healthy, safe medical treatment." The hospital has a number of advanced medical devices, particularly the first global model of the 64-multislice CT (Brilliance64, Philips) introduced to pursue more precise vascular examinations. The new Main Building will be completed in the spring of 2013, and the Annex in the spring of 2015. The number of beds will be 608, 1.5 times more than the actual number of beds.

Our center is equipped with numerous advanced medical devices, and our treatment of ischemic heart disease ranks among the top in Japan in both quality and volume.
We perform more than 3,000 PCI procedures (percutaneous coronary intervention) each year, demonstrating extensive experience and excellent outcomes.

In addition, we provide advanced treatment techniques for complex and difficult lesions.
We have performed more than 5,000 rotablator procedures in total, and have also introduced newer techniques such as shockwave therapy and the Diamondback system.

Location

〒270-2251
107-1, Kanagasaku, Matsudo-shi

Website

http://www.chibanishi-hp.or.jp

Facility Overview

【Location】
The hospital is located between Narita Airport and Haneda Airport, with access from both airports in approximately one hour. Central Tokyo can be reached in about 30 minutes.

【Medical Services】
If coronary artery disease is detected, examinations can be performed starting in the afternoon.

【Medical Equipment】
Angiography systems
256-slice multi-detector CT scanner
MRI systems
Angiography units (6)
Radioisotope systems (2)
MRI scanners (2)
CT scanners (4)
Kidney and ureteral stone lithotripsy system (1)
Dialysis machines (44)
Robot-assisted surgical system da Vinci Xi (2)
and others

Specialty

Department of Cardiology
Coronary Angiography (CAG)
Percutaneous Coronary Intervention (PCI / PTCA)

Available Programs

• Medical tourism International course (Chiba Nishi General Hospital)

  This is half a day course to check whole body fully utilizing medical instruments such as the most advanced MRI or 256 lines multi slice CT and performing careful health checkup and medical care.

  This is half a day course to check whole body fully utilizing medical instruments such as the most advanced MRI or 256 lines multi slice CT and performing careful health checkup and medical care.

  View Details

• Cardiac catheterization, transluminal coronary angioplasty (Chiba Nishi General Hospital)　

  Cardiac catheterization is a treatment that widens the narrowed part of the coronary artery. The procedure is performed to treat ischemic heart disease by widening part of the coronary artery that is stenosed by atheroma in order to increase the blood flow.

  【Target Diseases】 Ischemic heart disease (angina pectoris, myocardial infarction) 【Features】 Coronary catheter intervention is a treatment that widens narrowed coronary arteries to improve blood flow. In patients with ischemic heart disease, the coronary arteries narrowed by atherosclerotic plaques are expanded to increase blood flow to the heart. Our hospital has the highest number of coronary catheter intervention cases in Japan. Reference video https://www.youtube.com/watch?v=rZiLxiYaxr4 【Department】 Department of Cardiology 【Attending Physician】 Kazuo Misumi, MD, PhD Hospital Director / Chief of Cardiology 【Education and Licenses】 Graduated from Tokyo Medical and Dental University, 1982 Medical License – California, USA Medical License – Hawaii, USA 【Certifications and Professional Memberships】 Board-Certified Specialist, Japanese Society of Internal Medicine Board-Certified Cardiologist, Japanese Circulation Society Instructor and Councilor, Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) Councilor, Japanese Coronary Association Member, Japan Geriatrics Society

  View Details

• Department of Cardiovascular Surgery (Chiba Nishi General Hospital)

  We have introduced advanced robot-assisted cardiac surgery and practice team-based medical care aimed at promoting faster patient recovery.

  【Target Diseases】 Surgical treatment for adult heart diseases and aortic diseases. 【Features】 Our department performs more than 700 surgeries annually, including stent graft procedures and transcatheter aortic valve implantation (TAVI), making it one of the leading centers in Japan in terms of surgical volume. In recent years, we have actively promoted minimally invasive treatments that are less burdensome for patients. These include minimally invasive cardiac surgery (MICS) performed through small incisions, robot-assisted cardiac surgery using the da Vinci system, stent graft treatment for aortic aneurysms, and endoscopic surgery for atrial fibrillation (Wolf–Ohtsuka method). We continuously strive to improve and refine our advanced surgical techniques. 【Department】 Department of Cardiovascular Surgery 【Attending Physician】 Dr. Yoshitsugu Nakamura, MD, PhD 【Certifications and Professional Memberships】 Board-Certified Surgeon, Japan Surgical Society Board-Certified Cardiovascular Surgeon, Japanese Board of Cardiovascular Surgery Training Supervisor, Japanese Board of Cardiovascular Surgery Instructor of Minimally Invasive Cardiac Surgery, Japanese Society for Minimally Invasive Cardiac Surgery Councilor, Japanese Coronary Association Robo-Doc Pilot Certified (International Grade A / Domestic Grade A), Japan Society for Robotic Surgery Councilor, Japan Society for Robotic Surgery Certified Surgeon for Robotic Cardiac Surgery, Council for Robotic Cardiac Surgery Certified Proctor for Robotic Cardiac Surgery Board-Certified Surgeon, Japanese Association for Thoracic Surgery Member, Japanese Society for Cardiovascular Surgery Member, Japanese Circulation Society Member, Japanese Society for Coronary Artery Surgery Member, Japanese Society for Vascular Surgery Member, ISMICS Master Proctor for Perceval Sutureless Bioprosthesis The Best Doctors in Japan 2024–2025 Doctor of Doctors Network – Excellent Specialist Clinician 2024–2026

  View Details